These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27374158)

  • 21. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.
    Emerich DF; Cain CK; Greco C; Saydoff JA; Hu ZY; Liu H; Lindner MD
    Cell Transplant; 1997; 6(3):249-66. PubMed ID: 9171158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Protective effect of intrastriatal grafts in an experimental model of Huntington's disease. Behavioral and morphological correlation].
    Levivier M; Pearlman SH; Gash DM; Brotchi J
    Neurochirurgie; 1991; 37(3):148-59. PubMed ID: 1831884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
    Emerich DF; Bruhn S; Chu Y; Kordower JH
    Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration.
    Amin EM; Reza BA; Morteza BR; Maryam MM; Ali M; Zeinab N
    Neurol Res; 2008 Dec; 30(10):1086-90. PubMed ID: 18768110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and electrophysiological correlates of the quinolinic acid rat model of Huntington's disease in rats.
    Popoli P; Pèzzola A; Domenici MR; Sagratella S; Diana G; Caporali MG; Bronzetti E; Vega J; Scotti de Carolis A
    Brain Res Bull; 1994; 35(4):329-35. PubMed ID: 7850482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task.
    Shear DA; Dong J; Haik-Creguer KL; Bazzett TJ; Albin RL; Dunbar GL
    Exp Neurol; 1998 Apr; 150(2):305-11. PubMed ID: 9527900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral characterization of quinolinate-induced lesions of the medial striatum: relevance for Huntington's disease.
    Furtado JC; Mazurek MF
    Exp Neurol; 1996 Mar; 138(1):158-68. PubMed ID: 8593891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration.
    Ghorayeb I; Puschban Z; Fernagut PO; Scherfler C; Rouland R; Wenning GK; Tison F
    Exp Neurol; 2001 Jan; 167(1):133-47. PubMed ID: 11161601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease.
    Joel D; Ayalon L; Tarrasch R; Veenman L; Feldon J; Weiner I
    Brain Res; 1998 Mar; 787(1):143-8. PubMed ID: 9518584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats.
    Figueredo-Cardenas G; Chen Q; Reiner A
    Exp Neurol; 1997 Aug; 146(2):444-57. PubMed ID: 9270055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
    Colle D; Hartwig JM; Soares FA; Farina M
    Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplantation of GABAergic cells derived from bioreactor-expanded human neural precursor cells restores motor and cognitive behavioral deficits in a rodent model of Huntington's disease.
    McLeod MC; Kobayashi NR; Sen A; Baghbaderani BA; Sadi D; Ulalia R; Behie LA; Mendez I
    Cell Transplant; 2013; 22(12):2237-56. PubMed ID: 23127784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid.
    El Massioui N; Ouary S; Chéruel F; Hantraye P; Brouillet E
    Exp Neurol; 2001 Nov; 172(1):172-81. PubMed ID: 11681849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine anaesthesia interferes with the quinolinic acid-induced lesion in a rat model of Huntington's disease.
    Jiang W; Büchele F; Papazoglou A; Döbrössy M; Nikkhah G
    J Neurosci Methods; 2009 May; 179(2):219-23. PubMed ID: 19428530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. hESC-derived striatal progenitors grafted into a Huntington's disease rat model support long-term functional motor recovery by differentiating, self-organizing and connecting into the lesioned striatum.
    Schellino R; Besusso D; Parolisi R; Gómez-González GB; Dallere S; Scaramuzza L; Ribodino M; Campus I; Conforti P; Parmar M; Boido M; Cattaneo E; Buffo A
    Stem Cell Res Ther; 2023 Jul; 14(1):189. PubMed ID: 37507794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences.
    Kumar A; Chaudhary T; Mishra J
    Eur J Pharmacol; 2013 Nov; 720(1-3):16-28. PubMed ID: 24211676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain repair in a unilateral rat model of Huntington's disease: new insights into impairment and restoration of forelimb movement patterns.
    Klein A; Lane EL; Dunnett SB
    Cell Transplant; 2013; 22(10):1735-51. PubMed ID: 23067670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
    Vazey EM; Chen K; Hughes SM; Connor B
    Exp Neurol; 2006 Jun; 199(2):384-96. PubMed ID: 16626705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease.
    Gianfriddo M; Corsi C; Melani A; Pèzzola A; Reggio R; Popoli P; Pedata F
    Brain Res; 2003 Jul; 979(1-2):225-9. PubMed ID: 12850590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
    Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
    Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.